AmiLyfe Bioscience

AmiLyfe Bioscience is a leader in biomapping and electrophysiology, pioneering the discovery that novel amino acid combinations contribute to maintaining and restoring human health. The company delves deep into the cellular dynamics of natural amino acids, unearthing critical insights into their impact on essential physiological functions such as secretion, absorption, barrier integrity, and proliferation. Utilizing their advanced AI-powered platform, Maestro™, they identify biofunctional formulations that unlock solutions to enhancing health and wellbeing. Maestro™ has mapped over 1 quintillion possible combinations of amino acids and has identified over 50 biofunctional formulations targeting over 25 health territories including gut health, hydration, respiratory disease and skin care. All formulations have been clinically studied and proven to provide meaningful health benefits. The company works with notable partners including Vyvve, Nuvara, Reckitt, NASA, University of Florida, Monash University, and Baptist Health. AmiLyfe Bioscience acquired the assets of Entrinsic Bioscience to enhance their capabilities and broaden their product portfolio. The company is headquartered in Norwood, Massachusetts and focuses on addressing critical global health challenges through innovative amino acid research and development.